Close Menu

NEW YORK – Thermo Fisher Scientific said on Thursday that it is teaming up with NanoPin Technologies to develop liquid chromatography mass spectrometry (LC-MS) workflows for blood-based infectious disease detection.

Separately, Thermo Fisher said on Wednesday that it is partnering with Q-linea to commercialize the Swedish firm's automated antibiotic susceptibility testing instrument ASTar.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.